Could pizza consumption improve rheumatoid arthritis severity?

Investigating whether pizza and its ingredients modulated RA disease activity.

Addressing health inequalities: REP-EQUITY toolkit aims for fairer research representation

Researchers created the REP-EQUITY toolbox for capturing an equitable and representative sample for health research studies.

December 12, 2023

Alzheimer’s Variant May Cause Distinct Form of the Disease

The APOE4 variant may be more than just a genetic risk factor for Alzheimer’s disease, new data from several cohorts suggested. Clinical, pathological, and biomarker

May 7, 2024

Risk adjusted net present value: What is the current valuation of Enliven Therapeutics’s ELVN-002?

ELVN-002 is a small molecule commercialized by Enliven Therapeutics, with a leading Phase I program in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer

April 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.